Novel proteomic biomarkers, including retinol‐binding protein 4, alpha‐1 anti‐chymotrypsin, apolipoprotein C‐III, apolipoprotein L1, haptoglobin, and vitronectin, have been associated with kidney function and the diagnosis of CKD [35, 36]. This evidence concerns the gene APOL1 and chronic kidney disease.